Hall, W. (2023). Minimizing policy-biased appraisals of the evidence on cannabis and psychosis [10.3389/fpsyt.2022.1047860]. Frontiers in Psychiatry, 13. https://doi.org/10.3389/fpsyt.2022.1047860

Hall, W., Leung, J., & Carlini, B. H. (2023). Do not let the ideal be the enemy of good enough regulation [10.1111/add.16201]. Addiction, 118(6), 1009-1010. https://doi.org/10.1111/add.16201

Hall, W., Stjepanović, D., Dawson, D., & Leung, J. (2023). The implementation and public health impacts of cannabis legalization in Canada: a systematic review [10.1111/add.16274]. Addiction. https://doi.org/10.1111/add.16274

Hayes, N., Bagley, K., Hewlett, N., Elliott, E. J., Pestell, C. F., Gullo, M. J., Munn, Z., Middleton, P., Walker, P., Till, H., Shanley, D. C., Young, S. L., Boaden, N., Hutchinson, D., Kippin, N. R., Finlay-Jones, A., Friend, R., Shelton, D., Crichton, A., & Reid, N. (2023). Lived experiences of the diagnostic assessment process for fetal alcohol spectrum disorder: A systematic review of qualitative evidence [10.1111/acer.15097]. Alcoholism: Clinical and Experimental Research, 47(7), 1209-1223. https://doi.org/10.1111/acer.15097

Henriques Franca, M., Bharat, C., Novello, E., Hwang, I., Medina-Mora, M. E., Benjet, C., Andrade, L. H., Vigo, D. V., & Viana, M. C. (2023). Towards measuring effective coverage: critical bottlenecks in quality- and user-adjusted coverage for major depressive disorder in São Paulo metropolitan area, Brazil [10.1186/s13033-023-00583-w]. International Journal of Mental Health Systems, 17(1). https://doi.org/10.1186/s13033-023-00583-w

Hines, L. A., Jones, H. J., Hickman, M., Lynskey, M., Howe, L. D., Zammit, S., & Heron, J. (2023). Adverse childhood experiences and adolescent cannabis use trajectories: findings from a longitudinal UK birth cohort [10.1016/S2468-2667(23)00095-6]. The Lancet Public Health, 8(6), e442-e452. https://doi.org/10.1016/S2468-2667(23)00095-6

Hoorntje, E. T., Burns, C., Marsili, L., Corden, B., Parikh, V. N., Te Meerman, G. J., Gray, B., Adiyaman, A., Bagnall, R. D., Barge-Schaapveld, D. Q. C. M., Van Den Berg, M. P., Bootsma, M., Bosman, L. P., Correnti, G., Duflou, J., Eppinga, R. N., Fatkin, D., Fietz, M., Haan, E., . . . Ingles, J. (2023). Variant Location Is a Novel Risk Factor for Individuals with Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant [10.1161/CIRCGEN.121.003672]. Circulation: Genomic and Precision Medicine, 16(1), E003672. https://doi.org/10.1161/CIRCGEN.121.003672

Islam, S. M. S., Maddison, R., Uddin, R., Ball, K., Livingstone, K. M., Khan, A., Salmon, J., Ackerman, I. N., Adair, T., Adegboye, O. A., Ademi, Z., Adhikary, R. K., Ahinkorah, B. O., Alam, K., Alene, K. A., Alif, S. M., Amare, A. T., Ameyaw, E. K., Aminde, L. N., . . . Miller, T. R. (2023). The burden and trend of diseases and their risk factors in Australia, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 [10.1016/S2468-2667(23)00123-8]. The Lancet Public Health, 8(8), e585-e599. https://doi.org/10.1016/S2468-2667(23)00123-8

Jawa, R., Tin, Y., Nall, S., Calcaterra, S. L., Savinkina, A., Marks, L. R., Kimmel, S. D., Linas, B. P., & Barocas, J. A. (2023). Estimated Clinical Outcomes and Cost-effectiveness Associated with Provision of Addiction Treatment in US Primary Care Clinics [10.1001/jamanetworkopen.2023.7888]. JAMA Network Open, 6(4), E237888. https://doi.org/10.1001/jamanetworkopen.2023.7888

Jiang, N., Bruneau, J., Makarenko, I., Minoyan, N., Zang, G., Høj, S. B., Larney, S., & Martel-Laferrière, V. (2023). HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers [10.1016/j.drugpo.2023.103954]. International Journal of Drug Policy, 113. https://doi.org/10.1016/j.drugpo.2023.103954

Jones, F., & Sutherland, R. (2023). Mental and physical health and service access among people in Sydney who use illicit drugs, 2022 [10.26190/3xed-wg67].